Insider Trading: Alkermes Plc (ALKS.O)
ALKS.O on Nasdaq
33.00USD
23 May 2013
33.00USD
23 May 2013
Price Change (% chg)
$1.25 (+3.94%)
$1.25 (+3.94%)
Prev Close
$31.75
$31.75
Open
$30.10
$30.10
Day's High
$33.17
$33.17
Day's Low
$28.59
$28.59
Volume
2,452,706
2,452,706
Avg. Vol
1,336,611
1,336,611
52-wk High
$33.17
$33.17
52-wk Low
$14.82
$14.82
FRATES JAMES M
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 13 Mar 2013 | Buy | 7,000 | $14.57 | 96,207 |
| 13 Mar 2013 | Sell | 15,750 | $22.79 | 96,207 |
| 13 Mar 2013 | Buy | 8,750 | $9.97 | 96,207 |
| 13 Feb 2013 | Buy | 8,750 | $9.97 | 96,207 |
| 13 Feb 2013 | Sell | 8,750 | $21.34 | 96,207 |
| 15 Jan 2013 | Sell | 8,750 | $22.22 | 96,207 |
| 15 Jan 2013 | Buy | 8,750 | $9.97 | 96,207 |
| 30 Dec 2012 | Sell | 3,752 | $18.33 | 96,207 |
| 27 Dec 2012 | Sell | 3,752 | $18.76 | 96,207 |
| 4 Dec 2012 | Sell | 3,002 | $19.64 | 103,711 |
| 4 Dec 2012 | Buy | 3,002 | $7.36 | 103,711 |
| 27 Nov 2012 | Sell | 5,364 | $19.28 | 103,711 |
| 27 Nov 2012 | Buy | 5,364 | $7.36 | 103,711 |
| 20 Nov 2012 | Sell | 5,364 | $19.84 | 99,711 |
| 20 Nov 2012 | Buy | 5,364 | $7.36 | 99,711 |
| 17 Nov 2012 | Sell | 2,607 | $19.49 | 103,711 |
| 17 Nov 2012 | Buy | 6,250 | $0.00 | 103,711 |
| 13 Nov 2012 | Sell | 5,364 | $20.15 | 100,068 |
| 13 Nov 2012 | Buy | 5,364 | $7.36 | 100,068 |
| 12 Nov 2012 | Buy | 8,726 | $7.36 | 100,068 |
| 12 Nov 2012 | Sell | 3,180 | $20.19 | 100,068 |
| 12 Nov 2012 | Sell | 4,320 | $20.19 | 100,068 |
| 12 Nov 2012 | Buy | 8,750 | $9.97 | 100,068 |
| 16 Oct 2012 | Buy | 5,364 | $7.36 | 0 |
| 16 Oct 2012 | Sell | 5,364 | $19.83 | 0 |
Institutional Holders
| % Shares Owned: | 96.07% |
| # of Holders: | 237 |
| Total Shares Held: | 127,937,593 |
| 3 Mo. Net Change: | 6,720,639 |
| # New Positions: | 37 |
| # Closed Positions: | 24 |
| # Increased Positions: | 120 |
| # Reduced Positions: | 88 |
| # Net Buyers: | 32 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Richard Pops |
50 | 2011 | Chairman of the Board, Chief Executive Officer |
Shane Cooke |
50 | 2011 | President |
James Frates |
45 | 2011 | Chief Financial Officer, Senior Vice President |
Gordon Pugh |
54 | 2011 | Chief Operating Officer, Senior Vice President, Chief Risk Officer |
Kathryn Biberstein |
53 | 2011 | Senior Vice President, Chief Compliance Officer, General Counsel, Secretary |
James Botkin |
63 | 2011 | Senior Vice President - Operations |
Elliot Ehrich |
53 | 2011 | Senior Vice President - Research and Development, Chief Medical Officer |
Michael Landine |
58 | 2011 | Senior Vice President - Corporate Development |
Mark Stejbach |
49 | 2012 | Senior Vice President, Chief Commercial Officer |
Mark Skaletsky |
2011 | Lead Independent Director | |
Nancy Wysenski |
2013 | Director | |
David Anstice |
64 | 2011 | Independent Director |
Floyd Bloom |
75 | 2011 | Independent Director |
Robert Breyer |
68 | 2011 | Independent Director |
Wendy Dixon |
56 | 2011 | Independent Director |
Geraldine Henwood |
59 | 2011 | Independent Director |
Paul Mitchell |
59 | 2011 | Independent Director |

